Article
CD33 in Alzheimer's disease.
Molecular neurobiology - 1 Feb 2014
Jiang Teng, Yu Jin-Tai, Hu Nan, Tan Meng-Shan, Zhu Xi-Chen, Tan Lan
Abstract excerpt
The amyloid-beta peptide (Aβ) cascade hypothesis posits that Aβ accumulation is the fundamental initiator of Alzheimer's disease (AD), and mounting evidence suggests that impaired Aβ clearance rather than its overproduction is the major pathogenic event for AD. Recent genetic studies have identified cluster of differentiation 33 (CD33) as a strong genetic locus linked to AD. As a type I transmembrane protein,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
